Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
That is absolutely huge! I want to see a filing confirming it was closed but if they can follow through with that, this will be set up for a big move once they do get the FDA approval.
Fed announcement caused that I bet!
Tweet about 1 hr ago.
“We have completed our condensation testing. We have also completed our cleaning protocol and validation (instructions on how to properly clean our device). We anticipate submitting these results to the FDA some time next week”
Already 2 messages from them this morning;
https://mobile.twitter.com/RemsleepInc
Tweet from Remsleep;
We will no longer be looking to raise capital through RegA. We will be closing our offering.
ASCM on bid covering short. Won’t be long
Offering usually set a max price but are always done at the market. They probably need cash to move forward if and after they get FDA approval.
A lot of my good stocks had the same chart yesterday - good climb and then a downturn. Hopefully we head back up to where we were. Still holding in the .02s which is fantastic.
Isn’t the offering price .03? Why buy them when you can get them for.022?
I think there is an active offering still open here, so some dilution should be expected until that is complete.
https://www.otcmarkets.com/filing/html?id=15304078&guid=k9CwkF7exZSOB3h
It was for 526,229,517 shares
Did they partner with this new company to help them dilute or what?
No idea but quick opportunity to add some more.
Who had 10 mln shares to sell this morning?
It looks like they are done selling.
Agree 100%! GLTU
I've played this one quite a few times, usually buy .01-.015 range but it would always fall short before .03. Looks like we'll beat that this time. We're in the best position for news that we've been in just about ever IMO. The fact that it is staying over .02 for a few days is a really good sign.
I fell you, I bought sme .14's way back when the SS was very small. I have a pile much cheaper now. but still would love to see .20's
The thought of this going up to .12 again....I'd be doing alright!
Those days are in our future!
Ask stacker!!! This thing was on a rocket straight up.
Sorry I see it in there.
Do you want to add the most recent PR info?
Can you update the sticky with the most recent information.
Thank you. I just posted a better summary ????
Brief overview and DD RemSleep.
Team Tsunami!!!!
So much to look forward to over the next few months! We are just getting started!
Recent catalysts:
1. 20 year US Patent #10987481
2. 510k submission accepted (Empirical Technologies 100% approval rate)
3. Sample masks shipped out to early investors
4. 510k Update - FDA AI Request 10.28.21
5. Condensation Testing Completed 1.5.22
6. Investor Relations Firm Hired 1.24.22
It is clear RMSL passed the Condensation Testing. Expecting PR on the response to the FDA's AI request any day... Then the countdown begins!
Future catalysts:
1. FDA 510k Approval
2. Sales Estimates
3. Contracts and distribution agreements
4. Future patents and 510k applications
5. Buyout/Merger
This is not just a sleep apnea mask, it will also be the first and only mask that will be FDA approved to treat COPD and congestive heart failure.
Once in motion a wave cannot be stopped!
Looking good. Could be an interesting day!
Likely because this play trades at 2 cents. Last I checked one requirement for uplisting was a sustained pps of $4.
I’m in for the ride !
Tampa, FL, Jan. 24, 2022 (GLOBE NEWSWIRE) -- RemSleep Holdings Inc (OTC PINK: RMSL), a medical device manufacturer dedicated to forever changing the level of treatment provided to obstructive sleep apnea patients, is proud to announce that we have partnered with Preya Co and MCAP Mediawire to maximize our communication and exposure with current and potential shareholders in conjunction with refining and broadening our overall messaging and outreach. This is in anticipation and because of the overwhelming response from the public and medical field from our pending DeltaWave 510k approval and market release.
“We feel we owe it to our current and future investors to have partnered with a gold star firm to assist us with our investor relations moving forward. Maintaining an open line of communication with our shareholders and providing consistent, timely updates will only serve to add value to our company,” said Tom Wood, CEO of RemSleep.
Ms.Preya Narain, founder of Preya Co is an experienced microcap consultant based in New York. Her background as a highly active day-trader led her seeking to serve companies and investors with greater purpose, impact, positivity and perspective. In 2020, she assembled a team of high-performing professionals and formed Preya Co., a consulting team with over twenty years combined experience in OTC, OTCQB/QX, foreign and NASDAQ markets. Preya Co. currently serves as a Corporate Advisor, Investor Relations Manager, and Social Media Manager for several publicly traded companies in the space, as well as forensic research and extensive due diligence reports for issuers, shareholders, regulatory agencies and federal organizations.
MCAP Mediawire is a top contender in the news distribution arena, offering the number one press release, digital media and financial disclosure service for microcap and exchange listed companies. Their services give companies exposure to an audience of millions, including journalists, investors, day-traders, fund managers and social media/messaging platforms. This enables press releases, earnings statements, branded articles, shareholder updates, corporate achievements to reach a vast and diverse audience around the world.
We encourage our shareholders to visit our official Twitter account for RemSleep Holdings Inc at https://twitter.com/RemsleepInc.
Interesting and exciting news just hit.
Someone looking to enter.
Why are we talking about R/S? There is no mention of one as far as I know. Scare tactics? SS is still not THAT bad even though it had gone up quite a bit in the last two years.
It only makes no sense to the person that doesn't want to make sense of it. Trust me it makes a lot of sense
Fair enough. Still your statement doesn't make any sense.
Well sharing personal experience lets everyone know there are alternative thought processes that can be lent to a subject such as a reverse split. Hope this helps!
Your post is a bunch of words that don't really purvey any point.
If anything can be learned from an R/S is that while it gives temporary satisfaction it doesn’t do any good if the company does nothing to hold up the high value of itself. So yes I’d they R/S best to be very careful as to what the next move maybe
How about the R/S that destroyed shareholders a few times
Seems like a lot of tickers are down today.
Look at when this went to .04 - had a down day similar to this beforehand.
If this was the end of a pump we'd be back below .015 IMO
$RMSL pay attention to the last part of this p.r release:
Tampa, FL, Jan 05, 2022 (GLOBE NEWSWIRE via COMTEX) -- Tampa, FL, Jan. 05, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- REMSleep Holdings, Inc. (OTC PINK: RMSL): The company announces that testing for ISO 18562-4:2017 has been completed. We are actively compiling all necessary documentation to submit the analysis to the FDA to proceed with our current 510k application. Further updates will be forthcoming. We look forward to concluding our 510k application with the FDA very soon.
"We look forward to concluding our 510k application with the FDA very soon"
It means we are right around the corner everyone, patience.
$RMSL great close today, some periods of consolidations not bad and needed for a healthy climb up.
Followers
|
311
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
31338
|
Created
|
11/14/08
|
Type
|
Free
|
Moderators |
REMSleep Holdings, Inc. is engaged in the business of developing and distributing sleep apnea products. The Company focuses on offering optimum compliance and comfort for continuous positive airway pressure (CPAP) patients. Its DeltaWave CPAP interface (the DeltaWave) is a device to treat patients with sleep apnea. Its DeltaWave product is a nasal-pillows type interface that is designed with airflow characteristics to enable patients with sleep apnea to breathe normally. Its product is manufactured by mold makers. Its target market includes home care dealers, private sleep labs, product end users, sleep physicians, medical groups, sleep product distributors, hospitals, medical associations, such as the American academy of sleep medicine and the American sleep association. REMSleep LLC is its wholly owned subsidiary.
INDUSTRY
Medical Equipment & Supplies
CONTACT INFO
2202 N. WEST SHORE BLVD SUITE 200
TAMPA, FL
33607
United States
+1.912.5902001
https://www.remsleep.com/EXECUTIVE LEADERSHIP
Russell Finlay Bird
Chairman of the Board
Thomas J. Wood
Chief Executive Officer, Director
Jonathan B Lane
Chief Technology Officer, Vice President
https://www.fundable.com/remsleep
Share Structure
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |